OBJECTIVES: Chronic Chagas disease causes cardiopathy in 20-40% of the 8-10 million people affected. The prevalence of atherogenic factors increases rapidly in Latin America. Somatic, mental, behavioural and social characteristics of the 80,000 Latino migrants with Chagas disease in Europe are not known. We postulate that they may accumulate these factors for poor health--notably cardiovascular-outcomes. METHODS: This study took place at the Geneva University Hospitals in 2011. Latin American migrants with Chagas disease diagnosed in Geneva since 2008 were contacted. Interviews and blood tests assessed behavioural, socioeconomic, metabolic and cardiovascular factors. RESULTS: One hundred and thirty-seven patients (women: 84.7%; median age: 43 years) with chronic Chagas disease were included in the study. The majority were Bolivians (94.2%), undocumented (83.3%), uninsured (72.3%) and living below the Swiss poverty line (89.1%). Prevalence of obesity was 25.5%, of hypertension 17.5%, of hypercholesterolemia 16.1%, of impaired fasting glucose 23.4%, of diabetes 2.9%, of metabolic syndrome 16.8%, of anxiety 58.4%, of depression 28.5%, of current smoking 15.4% and of sedentary lifestyle 62.8%. High (>10%) 10-year cardiovascular risk affected 12.4%. CONCLUSIONS: Latin American migrants with Chagas disease accumulate pathogenic chronic conditions of infectious, non-transmissible, socioeconomic and behavioural origin, putting them at high risk of poor health, notably cardiovascular, outcomes. This highlights the importance of screening for these factors and providing interventions to tackle reversible disorders; facilitating access to care for this hard-to-reach population to prevent delays in medical interventions and poorer health outcomes; and launching prospective studies to evaluate the long-term impact of these combined factors on the natural course of Chagas disease.
OBJECTIVES:Chronic Chagas disease causes cardiopathy in 20-40% of the 8-10 million people affected. The prevalence of atherogenic factors increases rapidly in Latin America. Somatic, mental, behavioural and social characteristics of the 80,000 Latino migrants with Chagas disease in Europe are not known. We postulate that they may accumulate these factors for poor health--notably cardiovascular-outcomes. METHODS: This study took place at the Geneva University Hospitals in 2011. Latin American migrants with Chagas disease diagnosed in Geneva since 2008 were contacted. Interviews and blood tests assessed behavioural, socioeconomic, metabolic and cardiovascular factors. RESULTS: One hundred and thirty-seven patients (women: 84.7%; median age: 43 years) with chronic Chagas disease were included in the study. The majority were Bolivians (94.2%), undocumented (83.3%), uninsured (72.3%) and living below the Swiss poverty line (89.1%). Prevalence of obesity was 25.5%, of hypertension 17.5%, of hypercholesterolemia 16.1%, of impaired fasting glucose 23.4%, of diabetes 2.9%, of metabolic syndrome 16.8%, of anxiety 58.4%, of depression 28.5%, of current smoking 15.4% and of sedentary lifestyle 62.8%. High (>10%) 10-year cardiovascular risk affected 12.4%. CONCLUSIONS: Latin American migrants with Chagas disease accumulate pathogenic chronic conditions of infectious, non-transmissible, socioeconomic and behavioural origin, putting them at high risk of poor health, notably cardiovascular, outcomes. This highlights the importance of screening for these factors and providing interventions to tackle reversible disorders; facilitating access to care for this hard-to-reach population to prevent delays in medical interventions and poorer health outcomes; and launching prospective studies to evaluate the long-term impact of these combined factors on the natural course of Chagas disease.
Authors: Quinn Dufurrena; Farhad M Amjad; Philipp E Scherer; Louis M Weiss; Jyothi Nagajyothi; Jesse Roth; Herbert B Tanowitz; Regina Kuliawat Journal: Parasitol Res Date: 2016-12-24 Impact factor: 2.289
Authors: Fnu Nagajyothi; Regina Kuliawat; Christine M Kusminski; Fabiana S Machado; Mahalia S Desruisseaux; Dazhi Zhao; Gary J Schwartz; Huan Huang; Chris Albanese; Michael P Lisanti; Rajat Singh; Feng Li; Louis M Weiss; Stephen M Factor; Jeffrey E Pessin; Philipp E Scherer; Herbert B Tanowitz Journal: Am J Pathol Date: 2013-01-12 Impact factor: 4.307
Authors: Sandra M De Urioste-Stone; Pamela M Pennington; Elizabeth Pellecer; Teresa M Aguilar; Gabriela Samayoa; Hugo D Perdomo; Hugo Enríquez; José G Juárez Journal: Trans R Soc Trop Med Hyg Date: 2015-02 Impact factor: 2.184
Authors: Alejandro Marcel Hasslocher-Moreno; Sergio Salles Xavier; Roberto Magalhães Saraiva; Luiz Henrique Conde Sangenis; Marcelo Teixeira de Holanda; Henrique Horta Veloso; Andrea Rodrigues da Costa; Fernanda de Souza Nogueira Sardinha Mendes; Pedro Emmanuel Alvarenga Americano do Brasil; Gilberto Marcelo Sperandio da Silva; Mauro Felippe Felix Mediano; Andrea Silvestre de Sousa Journal: Trop Med Infect Dis Date: 2020-05-12
Authors: Rubens Antonio da Silva; Dalva Marli Valério Wanderley; Colin Forsyth; Ruth Moreira Leite; Expedito José de Albuquerque Luna; Nivaldo Carneiro Júnior; Maria Aparecida Shikanai-Yasuda Journal: Rev Inst Med Trop Sao Paulo Date: 2020-06-17 Impact factor: 1.846
Authors: Colin J Forsyth; Salvador Hernandez; Carmen A Flores; Mario F Roman; J Maribel Nieto; Grecia Marquez; Juan Sequeira; Harry Sequeira; Sheba K Meymandi Journal: Am J Trop Med Hyg Date: 2018-01-25 Impact factor: 2.345
Authors: Eileen Stillwaggon; Victoria Perez-Zetune; Stephanie R Bialek; Susan P Montgomery Journal: Am J Trop Med Hyg Date: 2018-04-26 Impact factor: 2.345